Abstract
BackgroundImmunotherapy success in solid cancers is largely dependent on the tumor microenvironment (TME) and its modulation is central to improve clinical outcomes. One of the key players regulating the TME...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
